Company finalizing preparations for end of January 2026 U.S. FDA Biologics License Application (BLA) submission for OST-HER2 ...
For children and young adults diagnosed with osteosarcoma, a common type of bone cancer for that age group, the odds of survival can be devastatingly low (20-30%) when the disease spreads to the lungs ...
A beloved Portsmouth woman who captured the hearts of thousands through her courageous fight against Osteosarcoma, has died, her mother announced Friday evening.
Detailed price information for Os Therapies Incorporated (OSTX-A) from The Globe and Mail including charting and trades.
Researchers working on a groundbreaking project that could transform how doctors detect and treat osteosarcoma, a rare but ...
New research at the University of Guelph offers renewed hope for both human and animal patients fighting osteosarcoma. This ...
Detailed price information for Os Therapies Incorporated (OSTX-A) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback